Meeting
2020 ASCO Virtual Scientific Program
Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases.
Authors
Lucy Storey
Christie NHS Foundation Trust, Manchester, United Kingdom
Lucy Storey , Mohammed Abdul-Latif , Sophia Kreft , Emma Barrett , Lisa M Pickering , Maartje W. Rohaan , Sobia Ahmed , Thomas K. Eigentler , Jessica Cecile Hassel , Sebastian Haferkamp , Frank Meiss , Theresa Steeb , Heather May Shaw , Christian U. Blank , Alexander Christopher Jonathan Van Akkooi , James M. G. Larkin , Bastian Schilling , Paul Lorigan , Paul D. Nathan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 38: 2020 (suppl; abstr 10070)
DOI
10.1200/JCO.2020.38.15_suppl.10070
Abstract #
10070
Poster Bd #
419
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2022 ASCO Annual Meeting
Neo-adjuvant T-VEC plus nivolumab combination therapy for resectable early-stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: The NIVEC trial.
First Author: Maartje W. Rohaan
Poster
2020 ASCO Virtual Scientific Program
Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.
First Author: Michael C. Lowe
![SECOMBIT (sequential combo immuno and target therapy study): A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with metastatic melanoma and BRAF mutation.](https://d201v5jt9ylckg.cloudfront.net/199/11950/153326/153326_poster_pv.jpg)
First Author: Paolo Antonio Ascierto